Zobrazeno 1 - 10
of 447
pro vyhledávání: '"Yong Sheng Wang"'
Publikováno v:
Journal of Asian Ceramic Societies, Vol 11, Iss 2, Pp 250-259 (2023)
ABSTRACTA high purity Al2O3 ceramic (HPAOC) metallizing strategy was developed via gradient coating process of metallizing pastes with different ratios of Mo to manganese glass (MnG) contents, to improve the wettability and reactivity of metallized l
Externí odkaz:
https://doaj.org/article/d1817365977342d599e0b1e66bff1ef5
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract Removal of confined space carbon dioxide (CO2) that is in low concentration and with coexisting water is necessary but challenging by physical adsorption method. To make the removal process effective, rendering the nanopore surface hydrophob
Externí odkaz:
https://doaj.org/article/2094974804824787809e088c2493efc4
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract For breast cancer patients with physical exam node negative but radiological finding node abnormal (cN0/rNa), the NCCN and ASCO guidelines recommend sentinel lymph node biopsy (SLNB) as the first-line axillary staging. However, patients who
Externí odkaz:
https://doaj.org/article/4640693d21434e27a07545a9a649312f
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThe distant metastasis of lung cancer primarily occurs in the bones, liver, brain, and lungs, while the breast is an extremely rare site of metastasis. There is very limited literature on the occurrence of breast metastasis from lung cancer
Externí odkaz:
https://doaj.org/article/03df023fe5fb465da80a070103544f73
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
PurposeThe purpose of this study was to provide advice for the indication of regional nodal irradiation (RNI) in patients with one to two positive sentinel lymph nodes (SLNs) without axillary lymph node dissection (ALND).MethodsWe conducted a retrosp
Externí odkaz:
https://doaj.org/article/77a5e1fd325f4ed29d8e605c0863a1a1
Autor:
Yong-Sheng Wang, Sheng-Ji Yang, Zi-Xuan Wan, Ao Shen, Muhammad Jamil Ahmad, Ming-Yue Chen, Li-Jun Huo, Jun-Hua Pan
Publikováno v:
Ecotoxicology and Environmental Safety, Vol 273, Iss , Pp 116100- (2024)
Chlorothalonil (CTL) is widely used in agricultural production and antifoulant additive globally due to its broad spectrum and non-systemic properties, resulting in its widespread existence in foods, soil and water. Extensive evidence demonstrated th
Externí odkaz:
https://doaj.org/article/4a2a4941187843eea061dbbca76b338f
Autor:
Yong-Sheng Wang, Sheng-Ji Yang, Muhammad Jamil Ahmad, Zhi-Ming Ding, Ze-Qun Duan, Yang-Wu Chen, Ming Liu, Ai-Xin Liang, Guo-Hua Hua, Li-Jun Huo
Publikováno v:
Ecotoxicology and Environmental Safety, Vol 234, Iss , Pp 113393- (2022)
Zinc Pyrithione (ZPT), a Food and Drug Administration (FDA) approved chemical, is widely used for topical antimicrobials and cosmetic consumer products, including anti-dandruff shampoos. ZPT and its degraded byproducts have detected in large quantiti
Externí odkaz:
https://doaj.org/article/0e8f28fb57bd4b96acda3c1f273e9b4a
Autor:
Chun-Hui Zheng, Kai Xu, Wen-Ping Shan, Ya-Kun Zhang, Zhi-De Su, Xiang-Jin Gao, Yu-Jue Wang, Jian-Yu Qi, Xiao-Yan Ding, Chun-Ping Wang, Yong-sheng Wang
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
BackgroundPatients with concentric shrinkage mode after neoadjuvant chemotherapy (NAC) is considered to be ideal candidates for breast conserving treatment (BCT). While, what proportion of patients would represent CSM have not been well defined. This
Externí odkaz:
https://doaj.org/article/177fdf7f2baf454785cfaee2b28e23cd
Autor:
Zhao Bi, Peng-Fei Qiu, Yue Zhang, Xing-Guo Song, Peng Chen, Li Xie, Yong-Sheng Wang, Xian-Rang Song
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeThe study aimed to explore whether the expression of lncRNAs in primary tumors could predict nodal efficacy after neoadjuvant therapy (NAT) for HER2+ breast cancer.MethodsTotal RNA was extracted from HER2+ breast cancer tissues before NAT (n=1
Externí odkaz:
https://doaj.org/article/53d85b73a3af4fffbba56f968f21c35f
Publikováno v:
Thoracic Cancer, Vol 10, Iss 4, Pp 1023-1028 (2019)
EGFR‐activating mutations have been recognized as the most important predictor of response to EGFR‐tyrosine kinase inhibitors (TKIs); however, 20–30% of patients harboring EGFR‐activating mutations show poor responses. The mechanisms of such
Externí odkaz:
https://doaj.org/article/481fe97d127046a98a3538e48d76f2c3